NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 1,768.00
-124.00 (-6.55%)
Oct 12, 2026, 3:30 PM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 174.8 billion as of October 12, 2026. It is the 23,497th most valuable company in the world and the 944th biggest in South Korea. Its market cap has decreased by 53.84% in one year.
Market Cap
174.80B
Enterprise Value
138.80B
Revenue
1.76B
Global Rank
Country Rank
#944 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 7.32T to 174.80B, a decrease of -97.61%. That is a compound annual growth rate of -48.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 174.80B | -56.93% |
| Dec 30, 2025 | 405.85B | -27.02% |
| Dec 30, 2024 | 556.13B | -44.44% |
| Dec 28, 2023 | 1.00T | -49.29% |
| Dec 29, 2022 | 1.97T | -61.23% |
| Dec 30, 2021 | 5.09T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SillaJen | 324.22B |
| HLB Therapeutics | 279.84B |
| Genomictree | 277.85B |
| GC Genome | 233.43B |
| GC Cell | 219.40B |
| Bioneer | 218.36B |
| Helixmith | 208.59B |
| Anterogen.Co.,Ltd. | 162.00B |